4,025
Views
166
CrossRef citations to date
0
Altmetric
Review

New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis

, &
Pages 413-422 | Published online: 09 Jan 2014

References

  • Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med.163(9), 1009–1021 (2003).
  • WHO. Global tuberculosis control. Surveillance, planning, financing. WHO Report 2005. WHO, Geneva, Switzerland 1–247 (2005).
  • Foulds J, O’Brien R. New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int. J. Tuberc. Lung Dis.2(10), 778–783 (1998).
  • Perkins MD. New diagnostic tools for tuberculosis. Int. J. Tuberc. Lung Dis.4(12 Suppl. 2), S182–S188 (2000).
  • Perkins MD, Small PM. Admitting defeat. Int. J. Tuberc. Lung Dis.10(1), 1 (2006).
  • Stop TB Partnership, WHO. The Global Plan to Stop TB 2006 – 2015. WHO, Geneva, Switzerland (2006).
  • Brodie D, Schluger NW. The diagnosis of tuberculosis. Clin. Chest Med.26(2), 247–271, vi (2005).
  • Palomino JC. Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. Eur. Respir. J.26(2), 339–350 (2005).
  • Hazbon MH. Recent advances in molecular methods for early diagnosis of tuberculosis and drug-resistant tuberculosis. Biomedica24(Supp 1), 149–162 (2004).
  • Nahid P, Pai M, Hopewell PC. Advances in the diagnosis and treatment of tuberculosis. Proc. Am. Thorac. Soc.3, 103–110 (2006).
  • American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med.161(4 Pt 2), S221–S247 (2000).
  • Menzies RI. Tuberculin skin testing. In: Tuberculosis: a Comprehensive International Approach. Reichman LB, Hershfield ES (Eds), Marcel Dekker, NY, USA, 279–322 (2000).
  • Menzies D. What does tuberculin reactivity after bacille Calmette–Guerin vaccination tell us? Clin. Infect. Dis.31(Suppl. 3), S71–S74 (2000).
  • Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis.4(12), 761–776 (2004).
  • Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA. Utility of the antigen-specific interferon-γ assay for the management of tuberculosis. Curr. Opin. Pulm. Med.11(3), 195–202 (2005).
  • Pai M. Alternatives to the tuberculin skin test: interferon-γ assays in the diagnosis of Mycobacterium tuberculosis infection. Indian J. Med. Microbiol.23(3), 151–158 (2005).
  • Lalvani A. Spotting latent infection: path to better tuberculosis control. Thorax58(11), 916–918 (2003).
  • Rothel JS, Andersen P. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev. Anti Infect. Ther.3(6), 981–993 (2005).
  • Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet356(9235), 1099–1104 (2000).
  • Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol.178(5), 1274–1282 (1996).
  • Mazurek GH, Jereb J, Lobue P et al. Guidelines for using the QuantiFERON-TB GOLD test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep.54(RR-15), 49–55 (2005).
  • Whalen CC. Diagnosis of latent tuberculosis infection: measure for measure. JAMA293(22), 2785–2787 (2005).
  • Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens. Am. J. Respir. Crit. Care Med.170(1), 59–64 (2004).
  • Ravn P, Munk ME, Andersen AB et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol.12(4), 491–496 (2005).
  • Kang YA, Lee HW, Yoon HI et al. Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA293(22), 2756–2761 (2005).
  • Pai M, Joshi R, Dogra S et al. Preliminary results from an evaluation of a whole-blood, interferon-γ assay in individuals with tuberculosis infection and disease in a rural Indian hospital. Int. J. Tuberc. Lung Dis.9(11), S262 (2005).
  • Lalvani A, Pathan AA, McShane H et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am. J. Respir. Crit. Care Med.163(4), 824–828 (2001).
  • Lalvani A, Nagvenkar P, Udwadia Z et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J. Infect. Dis.183(3), 469–477 (2001).
  • Pathan AA, Wilkinson KA, Klenerman P et al. Direct ex vivo analysis of antigen-specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol.167(9), 5217–5225 (2001).
  • Chapman AL, Munkanta M, Wilkinson KA et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS16(17), 2285–2293 (2002).
  • Liebeschuetz S, Bamber S, Ewer K et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet364(9452), 2196–2203 (2004).
  • Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur. J. Clin. Microbiol. Infect. Dis.24(8), 529–536 (2005).
  • Goletti D, Vincenti D, Carrara S et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a γ interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin. Diagn. Lab. Immunol.12(11), 1311–1316 (2005).
  • US Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR54(No.RR-17), 1–141 (2005).
  • Pai M, Joshi R, Dogra S et al. QuantiFERON-TB GOLD assay for serial testing in health care workers: boosting, conversions, and reversions. 10th Annual Meeting of the International Union Against Tuberculosis and Lung Disease (North American Region),IL, USA (2006)
  • Ewer K, Deeks J, Alvarez L et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet361(9364), 1168–1173 (2003).
  • Lalvani A, Pathan AA, Durkan H et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet357(9273), 2017–2021 (2001).
  • Pai M, Gokhale K, Joshi R et al.Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood, interferon-γ assay with tuberculin skin testing. JAMA293, 2746–2755 (2005).
  • Mahomed H, Hughes EJ, Hawkridge T et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-γ assay for tuberculosis infection. Int. J. Tuberc. Lung Dis.10(3), 310–316 (2006).
  • Hill PC, Brookes RH, Fox A et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin. Infect. Dis.38(7), 966–973 (2004).
  • Richeldi L, Ewer K, Losi M et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am. J. Respir. Crit. Care Med.170(3), 288–295 (2004).
  • Shams H, Weis SE, Klucar P et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am. J. Respir. Crit. Care Med.172(9), 1161–1168 (2005).
  • Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am. J. Respir. Crit. Care Med.170(1), 65–69 (2004).
  • Zellweger JP, Zellweger A, Ansermet S, de Senarclens B, Wrighton-Smith P. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int. J. Tuberc. Lung Dis.9(11), 1242–1247 (2005).
  • Dogra S, Narang P, Mendiratta DK et al. Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J. Infect. (2006) (In Press).
  • Ferrara G, Losi M, Meacci M et al. Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med.172(5), 631–635 (2005).
  • Pai M, Lewinsohn DM. Interferon-γ assays for tuberculosis: is anergy the Achilles’ heel? Am. J. Respir. Crit. Care Med.172(5), 519–521 (2005).
  • Dheda K, Lalvani A, Miller RF et al. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS19(17), 2038–2041 (2005).
  • Doherty TM, Demissie A, Olobo J et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J. Clin. Microbiol.40(2), 704–706 (2002).

Websites

  • Stop TB Working Group on New Diagnostics www.stoptb.org/wg/new_diagnostics
  • Foundation for Innovative New Diagnostics www.finddiagnostics.org
  • Tuberculosis Diagnostics Initiative, Special Programme for Research and Training in Tropical Diseases, WHO www.who.int/tdr/diseases/tb/tbdi.htm
  • Aeras Global Tuberculosis Vaccine Foundation http://aeras.org
  • Global Alliance for Tuberculosis Drug Development www.tballiance.org
  • Oxford Immunotec Ltd www.oxfordimmunotec.com
  • Cellestis, Ltd www.cellestis.com
  • US Centers for Disease Control and Prevention guidelines on QuantiFERON®-TB GOLD www.cdc.gov/mmwr/preview/mmwrhtml/ rr5415a4.htm
  • National Institute for Health and Clinical Excellence. Clinical Guideline 33. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE, London, UK, (2006). www.nice.org.uk/page.aspx?o=CG033NICEguideline

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.